This video is sponsored by the Duke Clinical Medical Series.
Peter Berger, MD, has indicated the following financial interest/relationships:
Research/grant support from Aventis, Conor, Guilford, Lumen, and Velocimed. Advisory Board
member for Genentech and Cordis/Johnson & Johnson. Medical Director and has equity
with Lumen, Inc.
David R. Holmes, Jr., MD has indicated he has no relationship with industry to disclose
relative to this CME activity.
|
|